Presenter Speech
Benjamin Yerxa (Executives)
Good morning, and thank you for joining us today to delve into our gene therapy pipeline with a focus on our earlier-stage programs. As a reminder, this
B
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.380 USD | -0.88% |
|
+10.82% | +68.16% |
| 01:44pm | TD Cowen Initiates Opus Genetics at Buy | MT |
| 07-09 | Opus Genetics Provides Update On OPGx-BEST1 Program With Detailed Timeline For OPGx-BEST1 Results | CI |
Published on 06/16/2026 at 09:50 pm BST - Modified on 06/25/2026 at 07:51 pm BST
Presenter Speech
Benjamin Yerxa (Executives)
Good morning, and thank you for joining us today to delve into our gene therapy pipeline with a focus on our earlier-stage programs. As a reminder, this
B
Select your edition
All financial news and data tailored to specific country editions